| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.96▼ | 3.02▼ | 3.01▼ | 3.42▼ | 3.38▼ |
| MA10 | 3.02▼ | 3.15▼ | 3.18▼ | 3.48▼ | 1.88▲ |
| MA20 | 3.22▼ | 3.38▼ | 3.42▼ | 3.22▼ | 1.33▲ |
| MA50 | 3.51▼ | 3.52▼ | 3.39▼ | 1.53▲ | 1.70▲ |
| MA100 | 3.51▼ | 3.23▼ | 3.03▼ | 1.14▲ | 14.09▼ |
| MA200 | 3.19▼ | 2.30▲ | 1.71▲ | 1.45▲ | 2,710.33▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.025▼ | -0.055▼ | -0.075▼ | -0.113▼ | 0.564▲ |
| RSI | 27.279▼ | 30.967▼ | 34.239▼ | 52.120▲ | 53.091▲ |
| STOCH | 4.340▼ | 4.445▼ | 2.500▼ | 53.969 | 37.385 |
| WILL %R | -98.276▼ | -98.780▼ | -98.980▼ | -76.250▼ | -65.422 |
| CCI | -97.763 | -111.312▼ | -117.058▼ | -77.985 | 86.297 |
|
Thursday, May 21, 2026 03:10 PM
Reported up to a 37% reduction of parenteral support in MVID patients and about 12% reduction in short bowel syndrome patients, as presented at NASPGHAN. Business development strategy -- Management ...
|
|
Tuesday, May 19, 2026 10:49 AM
First MVID patient enters the active treatment only extension phase after completion of randomized double-blind ...
|
|
Friday, May 15, 2026 03:06 PM
Detailed price information for Jaguar Health Inc (JAGX-Q) from The Globe and Mail including charting and trades.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 22/05/26 | 3.18 | 3.25 | 2.84 | 2.91 | 121,660 |
| 21/05/26 | 3.10 | 3.99 | 3.10 | 3.47 | 351,575 |
| 20/05/26 | 3.35 | 3.805 | 3.35 | 3.67 | 512,071 |
| 19/05/26 | 3.66 | 3.66 | 3.24 | 3.355 | 69,051 |
| 18/05/26 | 3.96 | 4.12 | 3.61 | 3.70 | 36,895 |
| 15/05/26 | 3.79 | 4.02 | 3.44 | 3.92 | 44,651 |
| 14/05/26 | 3.40 | 4.13 | 3.20 | 3.94 | 66,403 |
| 13/05/26 | 3.15 | 3.48 | 3.15 | 3.33 | 27,136 |
| 12/05/26 | 3.27 | 3.60 | 3.1201 | 3.25 | 37,070 |
| 11/05/26 | 2.97 | 3.45 | 2.87 | 3.30 | 99,085 |
|
|
||||
|
|
||||
|
|